2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary.
about
Antipsychotics for fibromyalgiaCannabinoids for fibromyalgiaCannabinoids for fibromyalgiaAntipsychotics for fibromyalgia in adultsClinical utility, safety, and efficacy of pregabalin in the treatment of fibromyalgiaEffects of non-pharmacological interventions on inflammatory biomarker expression in patients with fibromyalgia: a systematic reviewTherapeutic benefit of balneotherapy and hydrotherapy in the management of fibromyalgia syndrome: a qualitative systematic review and meta-analysis of randomized controlled trialsFibromyalgia: evolving concepts over the past 2 decades.Fibromyalgia and disability adjudication: no simple solutions to a complex problemControversies and challenges in fibromyalgia: a review and a proposalKeep it simple: easing the care burden of fibromyalgiaImpact of potential pregabalin or duloxetine drug-drug interactions on health care costs and utilization among Medicare members with fibromyalgia.An update on pharmacotherapy for the treatment of fibromyalgia.Pregabalin for pain in fibromyalgia in adults.Adjudication of fibromyalgia syndrome: challenges in the medicolegal arena.A patient and physician survey of fibromyalgia across Latin America and Europe.Multicomponent interdisciplinary group intervention for self-management of fibromyalgia: a mixed-methods randomized controlled trialFibromyalgia-related costs and loss of productivity: a substantial societal burden.The effects of add-on non-invasive brain stimulation in fibromyalgia: a meta-analysis and meta-regression of randomized controlled trials.Oral Burning With Dysphagia and Weight Loss.Fibromyalgia Outcomes Over Time: Results from a Prospective Observational Study in the United States.[Methodology report of the 2017 guidelines on fibromyalgia syndrome].Not the Last Word: Fibromyalgia is RealTowards Tailored Patient's Management Approach: Integrating the Modified 2010 ACR Criteria for Fibromyalgia in Multidimensional Patient Reported Outcome Measures Questionnaire.Decrease of fear avoidance beliefs following person-centered progressive resistance exercise contributes to reduced pain disability in women with fibromyalgia: secondary exploratory analyses from a randomized controlled trialEfficacy and safety of medicinal plants or related natural products for fibromyalgia: a systematic review.Fibromyalgia and Chronic Pain Syndromes: A White Paper Detailing Current Challenges in the Field.Additive Complex Ayurvedic Treatment in Patients with Fibromyalgia Syndrome Compared to Conventional Standard Care Alone: A Nonrandomized Controlled Clinical Pilot Study (KAFA Trial)Explaining unexplained pain to fibromyalgia patients: finding a narrative that is acceptable to patients and provides a rationale for evidence based interventions.Fibromyalgia Symptom Reduction by Online Behavioral Self-monitoring, Longitudinal Single Subject Analysis and Automated Delivery of Individualized Guidance.Treatment of fibromyalgia syndrome: recommendations of recent evidence-based interdisciplinary guidelines with special emphasis on complementary and alternative therapies.Classification and clinical diagnosis of fibromyalgia syndrome: recommendations of recent evidence-based interdisciplinary guidelines.Evaluating increased resource use in fibromyalgia using electronic health records.Development of a novel algorithm to determine adherence to chronic pain treatment guidelines using administrative claims.Beyond pain in fibromyalgia: insights into the symptom of fatigue.Review of pharmacological therapies in fibromyalgia syndrome.Clinical utility of the Hospital Anxiety and Depression Scale (HADS) for an outpatient fibromyalgia education program.Optimizing perioperative analgesia for the complex pain patient: medical and interventional strategies.Management of fibromyalgia in older adults.A systematic review of the efficacy of venlafaxine for the treatment of fibromyalgia.
P2860
Q24186761-0A7855DF-0A77-446F-961D-1399A6582536Q24188267-C5CAAD6B-C366-447D-9684-68AA8C188785Q26471052-CE3C202D-CA89-49CB-97DC-53AB0D215CC2Q26471557-2808C8A0-87CE-4186-9898-B8A0C1AA1621Q26764876-26A04F16-87C3-4A67-B5D0-4ACD664EE32BQ26786533-42DC2D10-26CC-4464-B4DF-00ECCC71C553Q26994991-68115FC5-3083-4ACB-89C6-9EBE7EC2C007Q26999442-1907A16F-3E96-45FA-8D74-3CD86A0F3AE6Q28649435-95147C5A-9987-40AA-A7F7-5427274D4903Q33572713-702B902A-48BC-4E46-8B4B-03F7E84DF48DQ33894699-79F00E9A-5AF9-47F7-AAF8-ACD225FE203FQ34379796-5D35C8B2-0F5A-4C06-A924-0FF226BA2309Q34477510-86E5FB69-C3B3-44AC-AC33-56C1B0F2A0A0Q34541472-9C548280-F550-475A-AFD8-A6DB8FA0A3ABQ34756165-161347D8-73B2-4C5F-8053-C8E041436B80Q34773454-6DA81B12-AD48-4A80-B9BF-C6D4836BB0C5Q35610478-D2A3B2AC-4BAE-4EA9-90D3-141A9083363BQ35991527-F5839ED2-5783-48FF-B862-57D83B5938DFQ36009941-7A333EA0-82A1-4D88-9D68-BC82AADC4E05Q36194787-72CBDCDE-6F80-494D-821D-D98C85E956C0Q36246938-BFD8AD40-DE6D-4BFE-AA5C-D9367351E834Q36368729-491E63AF-6FCD-4DBE-AB52-5C9476D1FE49Q36452594-995D9EA3-E893-4A9A-BB67-8891DE010DE8Q36840761-984458D0-02EE-4966-B747-498DE50F75FCQ36923412-6995227B-35FF-44D7-9D54-DBDC2C87E7E2Q36943343-4BC57BFB-809E-4F22-BDD6-B51B746C08B1Q37152958-C94F4BA1-E2E4-4ECD-BD76-A33F2EBCC8C1Q37173559-D835FA8E-2D1E-4119-A0E1-5AD401C3B454Q37197180-127D51FE-F99C-4518-A7F0-52A56B5C009AQ37283456-A1DCB311-1893-48C5-AA30-3A9F96185AF0Q37375687-E8E19291-45FB-473A-B160-AC9F7A8F087EQ37385744-3ABB4D03-1538-4B7C-AFE7-A532D8A77A07Q37426947-CBFED656-84AA-417E-BD04-7ACF3ACFD6C4Q37641488-AD62B1F2-EE06-4601-AC01-4D1F9E2DC86AQ37690090-7A87D472-4585-4B03-A09E-A230F59625D1Q37691161-5C0BD8FB-304B-47E3-AA5E-0990CA76109AQ38133359-7726A895-F835-44F6-9D0F-007B081377E3Q38163444-80D66DC8-1D47-4E6B-B2B8-A5617A4EED02Q38250183-259E64EE-DE8D-47DA-AD3C-682AFA9E734BQ38258054-BD1BE63B-BEDD-4F31-A471-B4628063C5D5
P2860
2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
2012 Canadian Guidelines for t ...... a syndrome: executive summary.
@en
type
label
2012 Canadian Guidelines for t ...... a syndrome: executive summary.
@en
prefLabel
2012 Canadian Guidelines for t ...... a syndrome: executive summary.
@en
P2093
P2860
P356
P1476
2012 Canadian Guidelines for t ...... a syndrome: executive summary.
@en
P2093
Don L Goldenberg
Dwight E Moulin
Johanne Proulx
John X Pereira
National Fibromyalgia Guideline Advisory Panel
Pantelis Panopalis
Peter A Ste-Marie
Susan Abbey
Yoram Shir
P2860
P304
P356
10.1155/2013/918216
P577
2013-05-01T00:00:00Z